Welcome to chemicalbook!
400-158-6606
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

ChemicalBook > Product Catalogue >Biochemical Engineering >Inhibitors >Metabolism >PDE inhibitors >Pimobendan

Pimobendan

Pimobendan Structure
  • ₹10825 - ₹46460.9
  • Product name: Pimobendan
  • CAS: 74150-27-9
  • MF: C19H18N4O2
  • MW: 334.37
  • EINECS:640-420-7
  • MDL Number:MFCD00761648
  • Synonyms:4,5-dihydro-6-[2-(4-methoxyphenyl)-1h-benzimidazol-5-yl]-5-methyl-3(2h)-pyridazinone;6-(2-(4-methoxyphenyl)-1H-benzo[d]imidazol-6-yl)-5-methyl-4,5-dihydropyridazin-3(2H)-one;6-(2-(4-Methoxyphenyl)-4,5-dihydro-1H-benzimidazol-5-yl)-5-methyl-3(2H)-pyridazinone;Pimobendan [inn-spanish];Pimobendane;Pimobendane [inn-french];Pimobendanum;PiMobendan(VetMedin)
3 prices
Selected condition:

Brand

  • Sigma-Aldrich(India)

Package

  • 10MG
  • 50MG
  • 200MG
  • ManufacturerSigma-Aldrich(India)
  • Product numberSML1333
  • Product descriptionPimobendan ≥98% (HPLC)
  • Packaging10MG
  • Price₹10825
  • Updated2022-06-14
  • Buy
  • ManufacturerSigma-Aldrich(India)
  • Product numberSML1333
  • Product descriptionPimobendan ≥98% (HPLC)
  • Packaging50MG
  • Price₹43613.93
  • Updated2022-06-14
  • Buy
  • ManufacturerSigma-Aldrich(India)
  • Product numberPHR3084
  • Product descriptionPimobendan pharmaceutical secondary standard, certified reference material
  • Packaging200MG
  • Price₹46460.9
  • Updated2022-06-14
  • Buy
Manufacturer Product number Product description Packaging Price Updated Buy
Sigma-Aldrich(India) SML1333 Pimobendan ≥98% (HPLC) 10MG ₹10825 2022-06-14 Buy
Sigma-Aldrich(India) SML1333 Pimobendan ≥98% (HPLC) 50MG ₹43613.93 2022-06-14 Buy
Sigma-Aldrich(India) PHR3084 Pimobendan pharmaceutical secondary standard, certified reference material 200MG ₹46460.9 2022-06-14 Buy

Properties

Melting point :approximate 243℃ (dec.)
Density :1.36
storage temp. :2-8°C
solubility :DMSO: soluble5mg/mL, clear (warmed)
form :powder
pka :10.55±0.10(Predicted)
color :white to beige
InChI :InChI=1S/C19H18N4O2/c1-11-9-17(24)22-23-18(11)13-5-8-15-16(10-13)21-19(20-15)12-3-6-14(25-2)7-4-12/h3-8,10-11H,9H2,1-2H3,(H,20,21)(H,22,24)
InChIKey :GLBJJMFZWDBELO-UHFFFAOYSA-N
SMILES :C1(=O)NN=C(C2C=C3NC(C4=CC=C(OC)C=C4)=NC3=CC=2)C(C)C1
CAS DataBase Reference :74150-27-9(CAS DataBase Reference)

Safety Information

Symbol(GHS): GHS hazard pictograms
Signal word: Danger
Hazard statements:
Code Hazard statements Hazard class Category Signal word Pictogram P-Codes
H301 Toxic if swalloed Acute toxicity,oral Category 3 Danger GHS hazard pictograms P264, P270, P301+P310, P321, P330,P405, P501
Precautionary statements:

Description

Pimobendan, a novel cardiotonic vasodilator, was introduced in Japan for the treatment of acute and mild to moderate chronic heart failure. It is a phosphodiesterase Ⅲ inhibitor and is able to enhance sensitization of myocardial contractile regulatory protein to calcium ions. The combination of these effects contribute to its inotropic activity. In patients with severe congestive heart failure, orally administered pimobendan improves cardiac index, stroke volume index, pulmonary wedge pressure, and systemic and pulmonary vascular resistance. Pimobendan is reported to be well tolerated and largely devoid of the proarrhythmic effects of classical phosphodiesterase Ill inhibitors. Studies also suggested that combination of the inotropic agent pimobendan with an ACE inhibitor such as enalapril may be superior to monotherapy for heart failure patients.